Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
New Strong Sell Stocks for May 17th
08:07am, Wednesday, 17'th May 2023
BIDU, EBS and FRO have been added to the Zacks Rank #5 (Strong Sell) List on May 17, 2023.
Why Emergent BioSolutions Stock Inched Slightly Higher Today
06:27pm, Monday, 15'th May 2023
It has sold off a clutch of assets to a European peer. It's received an upfront payment of $270 million, and could earn up to an additional $110 million in milestone payouts.
Emergent (EBS) Q1 Earnings Miss Estimates, Revenues Beat
12:12pm, Wednesday, 10'th May 2023
Emergent (EBS) reports wider-than-expected first-quarter loss. The company updates its 2023 guidance for selected categories.
Emergent BioSolutions Inc. (EBS) Q1 2023 Earnings Call Transcript
10:40pm, Tuesday, 09'th May 2023
Emergent BioSolutions Inc. (NYSE:EBS ) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Bob Burrows - VP, IR Bob Kramer - President and CEO Paul Williams - Senior Vice Pres
Emergent Biosolutions (EBS) Reports Q1 Loss, Tops Revenue Estimates
07:52pm, Tuesday, 09'th May 2023
Emergent Biosolutions (EBS) came out with a quarterly loss of $3.17 per share versus the Zacks Consensus Estimate of a loss of $1.67. This compares to earnings of $0.18 per share a year ago.
Emergent BioSolutions to Release First Quarter 2023 Financial Results and Conduct Conference Call on May 9, 2023
04:05pm, Wednesday, 19'th Apr 2023
GAITHERSBURG, Md., April 19, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, May 9, 2023, at 5:00 pm eastern time to discuss the financial resul
Emergent Biosciences (EBS) Surges 28% in a Week: Here's Why
10:39am, Monday, 03'rd Apr 2023
Shares of Emergent (EBS) have been rising following the FDA's approval to an OTC version of its Narcan nasal spray.
Emergent's (EBS) Narcan Gets OTC Status for Opioid Overdose
02:28pm, Thursday, 30'th Mar 2023
Following the FDA approval, Emergent's (EBS) Narcan nasal spray becomes the first OTC product approved for emergency treatment of opioid overdose. This product will be made available by late summer of
3 Stocks Capturing Options Traders' Attention
01:03pm, Thursday, 30'th Mar 2023
The major indexes are on the rise today, as Wall Street remains optimistic regarding the bank sector's recovery.
Why Emergent BioSolutions Stock Is Soaring Today
11:56am, Thursday, 30'th Mar 2023
The FDA approved the use of Narcan as an over-the-counter treatment for opioid overdoses on Wednesday. Narcan has been available as a prescription product in the U.S. since 2016.
Emergent Biosolutions (EBS) Surges 5.1%: Is This an Indication of Further Gains?
09:08am, Thursday, 30'th Mar 2023
Emergent Biosolutions (EBS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the n
Emergent Biosciences (EBS) Stock Pops as FDA Approves Over-the-Counter Narcan
11:48am, Wednesday, 29'th Mar 2023
In a fresh development for the medical and financial communities, the U.S. Food and Drug Administration (FDA) approved Emergent Biosciences' (NASDAQ: EBS ) Narcan nasal spray as an over-the-counter (
FDA approves over-the-counter sales of lifesaving opioid overdose treatment Narcan nasal spray
08:55am, Wednesday, 29'th Mar 2023
The FDA's decision means people will be able to buy the 4mg nasal spray without a prescription in supermarkets, convenience stores and vending machines.
Why Emergent BioSolutions Stock Is Sinking Today
11:16am, Friday, 17'th Mar 2023
J.P. Morgan analyst Jessica Fye downgraded Emergent BioSolutions from neutral to underweight. Fye also slashed the price target for the stock from $23 to $9.
Why Cassava Sciences Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
12:43pm, Thursday, 09'th Mar 2023 Benzinga
Gainers
Biophytis S.A. (NASDAQ: BPTS) rose 56.3% to $0.7895 in pre-market trading after the company said it presents positive results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COV
